BRIEF-Spero Therapeutics Appoints David Melnick As Chief Medical Officer By: Reuters: Company News January 04, 2018 at 07:35 AM EST * SPERO THERAPEUTICS APPOINTS DAVID MELNICK, M.D., AS CHIEF MEDICAL OFFICER Read More >> Related Stocks: Allergan Plc Spero Therapeutics Inc